Safety and Pharmacokinetics of Orally Administered Gallium Maltolate in Various Refractory Malignancies

Clinical trial NCT00050687 · TERMINATED

Trial details

NCT number: NCT00050687
Sponsor: Titan Pharmaceuticals
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Prostatic Neoplasms Multiple Myeloma Bladder Neoplasms Lymphoma

Start date: 2001-06-01
Primary completion: 2005-03-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.